New HIV strain doesn't cause AIDS...

27 November 1995

- Academic researchers in Australia, in collaboration with local pharmaceutical company AMRAD, believe they have identified a unique strain of HIV which does not cause AIDS. The team hopes that using this variant as the basis for research may yield an effective AIDS vaccine within the next five to 10 years. Details of the work are published in Science (November 10). Briefly, the scientists found that the non-pathogenic variant had a cluster of mutations in the nef gene and long terminal repeat region, which stopped it causing disease but did not impair replication. Primate studies have now shown that administration of a nef-deleted simian immunodeficiency virus did not cause disease and protected against challenge with virulent SIV.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight